Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Blog Post
October 17, 2023
There’s not a lot of low-hanging fruit in global development. On the issues that matter most, from preventing the next pandemic to expanding migration opportunities, and financing climate adaptation, even minor progress tends to require big financial commitments and often faces deep political resist...
POLICY PAPERS
October 12, 2023
The Multilateral Investment Guarantee Agency (MIGA), which offers investors and bankers political risk insurance and guarantees against non-payment by governments and state-owned enterprises, should feature heavily in the private sector reform agenda. We offer recommendations that would enable MIGA ...
Blog Post
October 12, 2023
As shareholders move forward with the World Bank’s Evolution Roadmap, they should take a closer look at the Multilateral Insurance Guarantee Agency (MIGA) and its potential to help advance the private sector agenda which has so far failed to deliver. The current version of the Roadmap includes opti...
Blog Post
October 09, 2023
Ahead of the highly-anticipated World Bank-IMF Annual Meetings in Marrakech, the Center for Global Development has unveiled a new tool to track reforms at the multilateral development banks. The Multilateral Development Bank (MDB) Reform Tracker is an innovative platform that explores how the six la...
Blog Post
September 21, 2023
The politics of antimicrobial resistance (AMR) has changed substantially since we launched the first CGD working group on AMR in 2007. There is now much more awareness about the need to act, even if global solutions have not yet been implemented. Countries including the UK, Canada, and Japan have an...
REPORTS
September 20, 2023
In our final working group report, we outline the principles of a Grand Bargain that we believe all stakeholders can and should sign up to during the UN General Assembly's High-Level Meeting on antimicrobial resistance in 2024. Explore our recommendations on increasing the availability of critically...
Blog Post
August 16, 2023
Despite verbal nods to global cooperation, equity, and solidarity, the COVID-19 pandemic laid bare a brutal realpolitik: all countries will put their citizens first and vaccinate their own populations, before offering charitable leftovers beyond their own borders. Sub-Saharan Africa, more than any o...
POLICY PAPERS
August 07, 2023
A main driver of antimicrobial resistance is the misuse and overuse of antimicrobials. But lack of access to antimicrobials causes a large mortality burden and contributes to the spread of resistant infections. How can learnings from the use of control policies in other areas of medicine be translat...
Blog Post
August 07, 2023
In a new paper, we argue that the idea of “stewardship”—and the tension between some stewardship policies and patient access—extends well beyond antimicrobials, to all drug classes. We consider the many reasons why governments opt to impose controls on medicines, and how rationales for control relat...